Parker Institute Showcases Advances in Cancer Immunotherapy at AACR 2026
The Parker Institute for Cancer Immunotherapy (PICI) is presenting significant research at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego. The event, running from April 17-22, features nearly 100 contributions from PICI leaders, investigators, and collaborators. These presentations highlight the institute's extensive work in cancer immunotherapy, including the largest plasma proteomics study for checkpoint inhibitor therapy and new methylation-based tools for monitoring tumor dynamics. Kristen Dahlgren, PICI's Chief of External Affairs, is co-chairing the meeting's program committee and leading sessions on improving trial efficiency and research impact. Antoni Ribas, Director of the PICI Center at UCLA, will receive the 2026 AACR-Margaret Foti Award for his leadership and achievements in cancer research. 
